Daiichi Sankyo Company, Limited

Daiichi Sankyo Appoints John Tsai, MD as Global Head of R&D

Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center Europe

Daiichi Sankyo Showcases Strength of Industry-Leading ADC Portfolio with Latest Research Updates from Five Landmark Breast Cancer Trials at SABCS

Federal Circuit Court of Appeals Vacates Infringement Judgment and Damages Award in Dispute between Daiichi Sankyo and Seagen

Daiichi Sankyo Continues to Transform Standards of Care for Patients with Three Landmark Breast Cancer Trials and Additional Data Across Industry-Leading ADC Portfolio at ESMO